January 2025

New study paves way for immunotherapies tailored for childhood cancers
21 January 2025

New study paves way for immunotherapies tailored for childhood cancers

Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s immune systems react to different kinds of cancer depending on their age. The study, which is published in the journal Cell, reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer.

21 January 2025
Drugs for Rare Diseases - New Brunswick Agreement

The Governments of Canada and the province of New Brunswick signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over 32 million USD over three years to improve access to new drugs for rare diseases for New Brunswick residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.

21 January 2025
Glenmark Pharma USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules
Glenmark Pharmaceuticals Inc., USA announces the launch1 of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules. Glenmark’s Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc., ANDA 087955.
21 January 2025
US exits WHO, Trump signs executive order

US withdraws from WHO after mishandling of the COVID-19 pandemic from WHO and signs executive order.

The United States noticed its withdrawal from the World Health Organization (WHO) in 2020 due to the organization’s mishandling of the COVID-19 pandemic that arose out of Wuhan, China, and other global health crises, its failure to adopt urgently needed reforms, and its inability to demonstrate independence from the inappropriate political influence of WHO member states.

20 January 2025
Job for M.Pharm, MSc, MTech to work in project funded by Uttar Pradesh Pollution Control Board at AIIMS
Postgraduate Degree M.Sc, M.Tech, M.Pharm, M.V.Sc in Biotechnology, Life Sciences, Microbiology, Medical Devices, Biological Sciences, Bioengineering, Biomedical Engineering, Allied Field with a minimum 60% marks or equivalent. Desirable Hands-on experience in molecular biology techniques, laboratory animal handling and experimentation, Histology work and toxico-pathological techniques.
20 January 2025
Job for Pharmacist at Haryana State AIDS Control Society
Bachelors degree in Pharmacy from a recognized institute. Or Diploma in Pharmacy. Candidate must be registered with State Pharmacy Council. Community candidates from HIV infected and affected and key communities.
20 January 2025
Vacancy for Pharmacists under Ministry of Defence
B.Pharmacy or Approved Diploma in Pharmacy from an Institute recognized by the Pharmacy Council of India and registered as Pharmacist under the Pharmacy Act 1948. Min 03 Yrs experience.
20 January 2025
Life Sciences Recruitment in an ICMR funded Research Project at IIT Hyderabad
First Class Post Graduate Degree, including the integrated PG degrees - Second Class Post Graduate Degree, including the Integrated PG degrees with PhD All allied areas of Life Sciences including Pharmacology, Bioengineering, Biotechnology, Biosciences and relevant fields will be considered.
20 January 2025
Job for Pharmacists in ECHS Polyclinics Kolkata
B.Pharma or 10+2 Science and Diploma in Pharmacy, minimum 03 years work experience. ECHS invites applications to engage following Medical, Para Medical and Non Med staff on contractual basis in ECHS Polyclinics viz Kolkata, Salt Lake, Howrah and Baruipur.
20 January 2025
Applications are invited for the post of Project Scientist at AIIMS Jodhpur
Post Graduate Degree Virology, Microbiology, including the integrated PG degrees with PhD. Strengthening genomic surveillance for vector borne diseases in India.